Does low free T3 reduce LDL receptor expression and raise LDL burden even with normal free T4?

Thyroid hormones serve as primary regulators of lipid metabolism, directly modulating the pathways responsible for clearing cholesterol from the bloodstream.

Molecular mechanisms of LDL regulation

• Active triiodothyronine (T3) acts as a ligand that activates hepatic thyroid hormone receptor beta (TRβ). The activated TRβ/RXRα complex binds directly to thyroid-responsive elements (TREs) on the LDL receptor (LDLR) promoter to rapidly induce gene transcription.
• T3 also controls the gene expression and activity of sterol regulatory element-binding protein 2 (SREBP-2), a transcription factor that binds to SRE-1 motifs on the LDLR promoter to further promote receptor expression.
• Consequently, a low free T3 state diminishes both TRβ activation and SREBP-2 activity, downregulating hepatic LDLR expression.

Impact on clearance and lipid burden

• Because hepatic LDLR expression dictates the clearance rate of circulating LDL, a reduction in these receptors decreases the fractional clearance of LDL particles from the bloodstream.
• This impaired hepatic clearance leads to the accumulation of LDL in plasma, directly elevating circulating LDL particle number (LDL-P) and total apolipoprotein B (ApoB) burden.
• This metabolic sequence can occur independently of serum free T4 levels. In clinical states like impaired peripheral T4-to-T3 conversion or non-thyroidal illness syndrome (NTIS), free T3 drops while free T4 remains normal, yet LDL clearance still declines due to the lack of active T3 at the hepatic level.

Bottom line

• Bottom line: Low free T3 downregulates hepatic LDL receptors through reduced TRβ and SREBP-2 pathway activation, leading to impaired LDL clearance and elevated LDL particle burden even when free T4 levels are normal.